# Efficacy and Tolerance of Full Field Peripheral Defocus Spectacles for the Control of Myopia Progression (Myofix Study)

> **NCT07092072** · NA · COMPLETED · sponsor: **Novar Corporation** · enrollment: 47 (actual)

## Conditions studied

- Myopia Progression

## Interventions

- **DEVICE:** MYOFIX FULL FIELD PERIPHERAL DEFOCUS SPECTACLE

## Key facts

- **NCT ID:** NCT07092072
- **Lead sponsor:** Novar Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-23
- **Primary completion:** 2024-04-23
- **Final completion:** 2024-04-23
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07092072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07092072, "Efficacy and Tolerance of Full Field Peripheral Defocus Spectacles for the Control of Myopia Progression (Myofix Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07092072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*